by Niels Masden and Claudio Lenz Cesaron on behalf of ALPHA
The ALPHA collaboration working on antihydrogen at the Antiproton Decelerator (AD) in building 193 has successfully expanded their setup with new devices.
by Pierre Pugnat on the behalf of the OSQAR collaboration
Two distinct OSQAR experiments at CERN, OSQAR-LSW and OSQAR-VMB look mostly for ALPS through studies of optical properties of the quantum vacuum permeated by a strong magnetic field
The ALICE experiment has recently released several measurements on the production of anti-deuterons and anti-3He that could help to understand AMS data.
Continuous improvements to the CLOUD facility as well as to the instruments combined with the state of the art know-how available at CERN have enabled a steady increase in the measurement capabilities.
Last week, the new CERN-MEDICIS facility has produced radioisotopes that will be used primarily for hospitals and research centres in Switzerland and across Europe.
Earlier in October, the Large Hadron Collider had a special run of colliding xenon nuclei; a new flavour compared to the standard proton and lead collisions foreseen in the LHC experimental programme.
LS2 period marks an exciting period of intense activity for MoEDAL, the LHC’s newest experiment.
The ALPHA collaboration working on antihydrogen at the Antiproton Decelerator (AD) in building 193 has successfully expanded their setup with new devices.
Two distinct OSQAR experiments at CERN, OSQAR-LSW and OSQAR-VMB look mostly for ALPS through studies of optical properties of the quantum vacuum permeated by a strong magnetic field
The ALICE experiment has recently released several measurements on the production of anti-deuterons and anti-3He that could help to understand AMS data. 
In a paper published this week in Nature, the ALPHA collaboration reports the most precise direct measurement of antimatter ever made
GBAR antimatter experiment sees first beam of positrons from a small electron linear accelerator. 
Last week, the new CERN-MEDICIS facility has produced radioisotopes that will be used primarily for hospitals and research centres in Switzerland and across Europe. 
Earlier in October, the Large Hadron Collider had a special run of colliding xenon nuclei; a new flavour compared to the standard proton and lead collisions foreseen in the LHC experimental programme.